Corrigendum to 'A linear prognostic score based on the ratio of interleukin-6 to interleukin-10 predicts outcomes in COVID-19'
journal contributionposted on 2022-03-07, 16:41 authored by Oliver McElvaney, Brian D Hobbs, Dandi Qiao, Oisin McelvaneyOisin Mcelvaney, Matthew Moll, Natalie McEvoy, Jennifer ClarkeJennifer Clarke, Eoin O'Connor, Sean Walsh, Michael H Cho, Gerard CurleyGerard Curley, Noel G McElvaneyNoel G McElvaney
The authors wish to correct a typographical error in the manuscript. In both the abstract and Section 3.4 of the original manuscript, a 1-point increase in the Dublin-Boston score was described as being associated with a 5.6 times increased odds (OR 5.62, 95% CI = 3.229.81, P = 1.2 £ 109 ) for a more severe outcome. While the OR and P-value stated are correct, the CI should instead have read “3.229.81”. The CI listed in Table 3 of the original manuscript, which accompanied Section 3.4, is correct. The authors regret any confusion caused, and appreciate the opportunity to correct this mistake.
CommentsThe original article is available at https://www.thelancet.com/ Corrigendum for EBioMedicine. 2020;61:103026. https://doi.org/10.1016/j.ebiom.2020.103026
Published CitationMcElvaney OJ. et al. Corrigendum to 'A linear prognostic score based on the ratio of interleukin-6 to interleukin-10 predicts outcomes in COVID-19'. EBioMedicine. 2020;62:103116
Publication Date10 November 2020
- Anaesthetics and Critical Care
- Beaumont Hospital
- Published Version (Version of Record)